Because the mechanism of adverse reactions to abrupt cessation of propranolol in patients with coronary heart disease was an enigma, we studied the effect of cessation of propranolol on beta-adrenergic receptor reactivity to catecholamine stimulation. The cyclic AMP concentrations in plasma and left ventricular muscle after the administration of isoproterenol (5mg/Kg) were measured in rats before, during, 2 days after, and 4 days after of the administration of propranolol (5mg/Kg).
HERE have been warnings that an abrupt cessation of propranolol treatment in patients with coronary heart disease may be hazardous. Slome1) reported that an abrupt cessation of propranolol was followed by myocardial infarction.
Miller et al2) described serious exacerbation of symptoms of coronary heart disease following the sudden withdrawal of propranolol after crossover to placebo during a double blind trial of propranolol in the treatment of angina pectoris.
Today, with the widespread use of propranolol in patients with ischemic In propranolol and withdrawal groups, rats were injected a solution of propranolol, 2mg/ml in normal saline, at a dose of 5mg/Kg. In control group, rats were injected similar volume of saline. In control, rats were given water containing no medicine.
Jap. Heart J. Increases in cyclic AMP after the administration of isoproterenol of 2 days' and 4 days' withdrawal groups are larger than that of control.
Jap. Heart J. the administration of isoproterenol were significantly increased as compared with that in control group (p<0.01). On the other hand, that in withdrawal 4 days group showed a tendency to have higher value. However, this was statistically not significant.
DISCUSSION
The propranolol withdrawal syndrome was first described in a series of case reports.4) Miller et al2) noted a 50% incidence of this phenomenon. But most authors now agree that this phenomenon occurs infrequently as compared to previous reports in the literature and Shand and Wood5) have described that its incidence is probably 5%. It is also generally agreed that the problems of this phenomenon occurred more often in patients who maintained normal activity than in patients in the hospital.6) Several mechanisms have been proposed to explain this phenomenon. One of the suggestions was that the ischemic heart disease process progressed, or that the patients continued to attempt the more strenuous activity that propranolol treatment had allowed. Diaz et al4) suggest that beta blockade permits the asymptomatic progression of coronary atherosclerosis while protecting the patient from the effects of this progression, namely, angina pectoris and possible myocardial infarction, by lowering myocardial oxygen requirements. When beta blockade (propranolol) is abruptly removed and oxygen requirements suddenly increase, the oxygen delivery system is no longer capable of meeting this renewed increase in oxygen demand, resulting in severe angina pectoris or myocardial infarction. Schrumpf et al7) reported that propranolol therapy decreased affinity of hemoglobin for oxygen and improved tissue availability of oxygen. Abrupt cessation of propranolol may possibly result in adverse alterations in oxygen affinity for hemoglobin. Another possible explanation of this phenomenon may be related to the effects of propranolol on platelet aggregation.8) An alternative explanation has been provided by Alderman et al9) who suggest true rebound phenomenon. Up to now, no satisfactory explanation of this phenomenon has been demonstrated and its mechanism is undefined.
Boudoulas et al10) showed a significant rebound increase in heart rate, pulse pressure, and shortening of electromechanical systole produced by isoproterenol in normal volunteers after 2 days' propranolol administration. Although this theory is an attractive one, negative reports do exist. Myers and Horwitz11) have failed to show increased sensitivity to epinephrine or isoproterenol in dogs. The area of greatest interest has been whether there is a true rebound hyperadrenergic state or not. So, we carried out this study to ascertain from the point of biochemical and pharmacological responses whether existed a hypersensitivity of the beta receptor to adrenergic stimuli after an abrupt cessation of propranolol. Barnes et al12) reported that increasing dose of isoproterenol, a potent beta adrenergic receptor agonist, resulted in linear increases in heart rate and dP/dt max, an index of myocardial contractile force. Rall13) found a rise in the plasma cyclic AMP concentration after intravenous application of catecholamine. Cyclic AMP is believed to be an intracellular second messenger of catecholamine action. The role of cyclic AMP as a second messenger reflects its ability to translate the initial message generated by the arrival at the cell surface of a hormone (catecholamine) into a second message that can be recognized within the cell. This second message is carried by cyclic AMP, which is produced from ATP by an enzyme called adenylate cyclase. This enzyme is activated when the catecholamine hormones interact with beta receptors located on the cell membrane. Thus, there are some correlations between the inotropic effect of catecholamine and cyclic AMP formation. If there is a true rebound hyperadrenergic state after an abrupt cessation of propranolol, it may be expected that withdrawal of propranolol produces a marked rebound increase of cyclic AMP formation, a reflection of the increased adenylate cyclase and/or there Jap. Heart J, May, 1980 is a hypersensitivity of the beta receptor to adrenergic stimuli as compared with normal condition. Therefore, the measurements of cyclic AMP concentrations in plasma and left ventricular muscle after the administration of isoproterenol would be expected to provide a reliable means of biochemical assessing cardiac sensitivity to catecholamine. In view of the fact that the most obvious changes shown by Boudoulas et al10) in man occurred at 36 and 48 hours after an abrupt cessation of propranolol, we measured the cyclic AMP concentrations before and after the administration of isoproterenol at 2 days and 4 days post-withdrawal of propranolol. In this study, the cyclic AMP concentrations in plasma before the administration of isoproterenol did not show any significant differences among 4 groups. While, the cyclic AMP concentrations in plasma after the administration of isoproterenol increased in all groups, but increases at 2 days and 4 days after withdrawal from propranolol were significantly large. This increased response to isoproterenol could be observed also in left ventricular muscle 2 days after withdrawal from propranolol. On the other hand, that of withdrawal 4 days group showed a tendency to have higher value but this was statistically not significant. According to this study, there is an evidence that an abrupt cessation of propranolol is associated with the development of greater than normal sensitivity to isoproterenol. We have shown that an abrupt cessation of propranolol after chronic administration is followed by transient hypersensitivity to catecholamine. The time course of this phenomenon was short and the response to isoproterenol at 4 days after withdrawal from propranolol returned to control condition.
Our findings of beta adrenergic hypersensitivity after propranolol withdrawal are supported by Boudoulas et al.10) However, Myers and Horwitz11) have failed to show increased sensitivity to isoproterenol. The most obvious changes shown by Boudoulas and our study occurred around 48 hours after an abrupt cessation of propranolol. Myers performed no measurements between 24 and 72 hours after cessation. Although species variation cannot be excluded, this discrepancy is probably due to time variation of blood sampling.
Possible mechanisms of this hyperadrenergic state include increased number of beta adrenergic receptor binding sites and altered affinity of beta receptors for catecholamines. Glaubiger and Lefkowitz14) have reported that treatment of rats with propranolol for 2 weeks leads to a 100% increase in the number of beta adrenergic receptors. Our study do not allow a conclusive explanation for mechanism of hyperadrenergic state.
In conclusion, we found that there was a rebound hyperadrenergic state after an abrupt cessation of long-term propranolol treatment. 
